Artiva Biotherapeutics Inc (ARTV)
11.96
+0.74
(+6.60%)
USD |
NASDAQ |
Nov 05, 16:00
11.96
0.00 (0.00%)
After-Hours: 20:00
Artiva Biotherapeutics Revenue (Quarterly): 0.251M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.251M |
March 31, 2023 | 0.989M |
March 31, 2022 | 1.348M |
Date | Value |
---|---|
December 31, 2021 | 1.422M |
March 31, 2021 | 0.111M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.111M
Minimum
Mar 2021
1.422M
Maximum
Dec 2021
0.8242M
Average
0.989M
Median
Mar 2023
Revenue (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 2.40M |
Palatin Technologies Inc | 0.35M |
iBio Inc | 0.175M |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -13.96M |
Total Expenses (Quarterly) | 14.74M |
EPS Diluted (Quarterly) | -0.7941 |
Enterprise Value | 135.15M |
Profit Margin (Quarterly) | -5.56K% |
Earnings Yield | -25.77% |
Normalized Earnings Yield | -25.64 |